Health ❯ Healthcare ❯ Clinical Trials

Patient Outcomes

Survival Rates Treatment Efficacy Quality of Life Remission Rates Efficacy and Safety Gender Differences Risk Stratification Mortality Rates Drug Efficacy Treatment Response

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

The company said it will seek U.S. approval by filing a Biologics License Application for Zenkuda in Q4 to pursue its first commercial product.

NHS Launches Pilot to Cut Brain Tumour Diagnosis from Weeks to Hours

Oral Vitamin C Shows Biological Signals in Phase 2 EVITA Trial

AstraZeneca's Tozorakimab Cuts COPD Flare‑Ups in Two Phase 3 Trials

FDA Approves Zanvastro as First Treatment for Alexander Disease

Tailored Antibiotic Strategy Shortens Therapy for Left‑Sided Endocarditis

FDA Approves Rasonque, an Oral KRAS Inhibitor, for Metastatic Pancreatic Cancer

Cold Platelets Stored Up to 21 Days Are Clinically Noninferior in Cardiac Surgery

FDA Approves Orzeyful as First Orexin Agonist for Narcolepsy Type 1

NHS to Offer Fampridine to Thousands With Multiple Sclerosis

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

NHS to Trial Wearable Monitors to Cut Sepsis Deaths

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

NHS CAR‑T Puts Most Trial Lupus Patients Into Remission

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

NHS Approves First New Ovarian Cancer Drug in 20 Years

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Boehringer’s Zongertinib Wins China Conditional Approval as ASCO Data Show Patient Benefit and Broader Activity